245 related articles for article (PubMed ID: 31257114)
1. Monitoring radiotherapy induced tissue changes in localized prostate cancer by multi-parametric magnetic resonance imaging (MP-MRI).
Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
Diagn Interv Imaging; 2019 Nov; 100(11):699-708. PubMed ID: 31257114
[TBL] [Abstract][Full Text] [Related]
2. Quantitative 3T multiparametric MRI of benign and malignant prostatic tissue in patients with and without local recurrent prostate cancer after external-beam radiation therapy.
Dinis Fernandes C; van Houdt PJ; Heijmink SWTPJ; Walraven I; Keesman R; Smolic M; Ghobadi G; van der Poel HG; Schoots IG; Pos FJ; van der Heide UA
J Magn Reson Imaging; 2019 Jul; 50(1):269-278. PubMed ID: 30585368
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?
Donati OF; Jung SI; Vargas HA; Gultekin DH; Zheng J; Moskowitz CS; Hricak H; Zelefsky MJ; Akin O
Radiology; 2013 Aug; 268(2):440-50. PubMed ID: 23481164
[TBL] [Abstract][Full Text] [Related]
4. Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancer.
Chung MP; Margolis D; Mesko S; Wang J; Kupelian P; Kamrava M
J Med Imaging Radiat Oncol; 2014 Oct; 58(5):588-94. PubMed ID: 25196228
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric quantitative analysis of tumor perfusion and diffusion with 3T MRI: differentiation between benign and malignant soft tissue tumors.
Lee SK; Jee WH; Jung CK; Chung YG
Br J Radiol; 2020 Nov; 93(1115):20191035. PubMed ID: 32649224
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast enhanced MRI monitoring of primary proton and carbon ion irradiation of prostate cancer using a novel hypofractionated raster scan technique.
Bonekamp D; Wolf MB; Edler C; Katayama S; Schlemmer HP; Herfarth K; Röthke M
Radiother Oncol; 2016 Aug; 120(2):313-9. PubMed ID: 27237059
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images.
Abd-Alazeez M; Ramachandran N; Dikaios N; Ahmed HU; Emberton M; Kirkham A; Arya M; Taylor S; Halligan S; Punwani S
Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):128-36. PubMed ID: 25644248
[TBL] [Abstract][Full Text] [Related]
9. 4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study.
Beer L; Polanec SH; Baltzer PAT; Schatzl G; Georg D; Schestak C; Dutschke A; Herrmann H; Mazal P; Brendel AK; Shariat SF; Ringl H; Helbich TH; Apfaltrer P
PLoS One; 2019; 14(12):e0225673. PubMed ID: 31856177
[TBL] [Abstract][Full Text] [Related]
10. Nine-year Follow-up for a Study of Diffusion-weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance Cohort.
Henderson DR; de Souza NM; Thomas K; Riches SF; Morgan VA; Sohaib SA; Dearnaley DP; Parker CC; van As NJ
Eur Urol; 2016 Jun; 69(6):1028-33. PubMed ID: 26482887
[TBL] [Abstract][Full Text] [Related]
11. Restriction spectrum imaging improves MRI-based prostate cancer detection.
McCammack KC; Schenker-Ahmed NM; White NS; Best SR; Marks RM; Heimbigner J; Kane CJ; Parsons JK; Kuperman JM; Bartsch H; Desikan RS; Rakow-Penner RA; Liss MA; Margolis DJ; Raman SS; Shabaik A; Dale AM; Karow DS
Abdom Radiol (NY); 2016 May; 41(5):946-53. PubMed ID: 26910114
[TBL] [Abstract][Full Text] [Related]
12. Compressed Sensing Radial Sampling MRI of Prostate Perfusion: Utility for Detection of Prostate Cancer.
Winkel DJ; Heye TJ; Benz MR; Glessgen CG; Wetterauer C; Bubendorf L; Block TK; Boll DT
Radiology; 2019 Mar; 290(3):702-708. PubMed ID: 30599102
[TBL] [Abstract][Full Text] [Related]
13. Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI.
Hötker AM; Mazaheri Y; Zheng J; Moskowitz CS; Berkowitz J; Lantos JE; Pei X; Zelefsky MJ; Hricak H; Akin O
Eur Radiol; 2015 Sep; 25(9):2665-72. PubMed ID: 25820537
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric MRI Tumor Probability Model for the Detection of Locally Recurrent Prostate Cancer After Radiation Therapy: Pathologic Validation and Comparison With Manual Tumor Delineations.
Dinis Fernandes C; Simões R; Ghobadi G; Heijmink SWTPJ; Schoots IG; de Jong J; Walraven I; van der Poel HG; van Houdt PJ; Smolic M; Pos FJ; van der Heide UA
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):140-148. PubMed ID: 31085288
[TBL] [Abstract][Full Text] [Related]
15. Dynamic gadolinium-enhanced perfusion MRI of prostate cancer: assessment of response to hypofractionated robotic stereotactic body radiation therapy.
Low RN; Fuller DB; Muradyan N
AJR Am J Roentgenol; 2011 Oct; 197(4):907-15. PubMed ID: 21940578
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted MRI Provides a Useful Biomarker for Evaluation of Radiotherapy Efficacy in Patients with Prostate Cancer.
Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
Anticancer Res; 2017 Sep; 37(9):5027-5032. PubMed ID: 28870929
[TBL] [Abstract][Full Text] [Related]
17. Biparametric 3T Magnetic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2?
Stanzione A; Imbriaco M; Cocozza S; Fusco F; Rusconi G; Nappi C; Mirone V; Mangiapia F; Brunetti A; Ragozzino A; Longo N
Eur J Radiol; 2016 Dec; 85(12):2269-2274. PubMed ID: 27842676
[TBL] [Abstract][Full Text] [Related]
18. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
[TBL] [Abstract][Full Text] [Related]
19. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.
Sun C; Chatterjee A; Yousuf A; Antic T; Eggener S; Karczmar GS; Oto A
AJR Am J Roentgenol; 2019 Feb; 212(2):351-356. PubMed ID: 30540213
[TBL] [Abstract][Full Text] [Related]
20. A prospective, multi-centre trial of multi-parametric MRI as a biomarker in anal carcinoma.
Jones M; Hruby G; Coolens C; Driscoll B; Stanwell P; Kumar M; Capp A; Sridharan S; Arm J; Gallagher S; Holder C; Oldmeadow C; Martin J
Radiother Oncol; 2020 Mar; 144():7-12. PubMed ID: 31710944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
